*

Curriculum Vitae

SUMMARY

My training in basic research, and my experience as Director of Medical Affairs for Pharmaxis and my

experience in applied and clinical research make me a strong candidate for this position. My academic

experience as Directors of Physiology and Respiratory Physiology Laboratories, my college teaching

experience, my role as a KOL (Thought Leader) for Merck and my clinical research in respiratory and

cardiovascular disease enhance my background. As Director of Medical Affairs for Pharmaxis, I performed

writing for marketing and regulatory, prepared white papers, product medical information letters, preparing

and updating “frequently asked questions document”, product monograph, produced slide presentations and

presented both in person and via webinars to the medical community. I acted as point-person for adverse

event reports and customer information while working closely with sales personnel, and acted as

Scientific/Medical Liaison with medical customers, I interfaced with identified KOLs, and reviewed grant

proposals for investigator initiated studies. As a researcher and P.I. of Phase II, III and IV clinical trials, I

have successfully endured an FDA Audit with no violations. I have been on numerous Editorial boards for

scientific journals. My publication record is substantial and I have written many scientific papers, book

chapters, one Book and have been successful in writing grant proposals. Two of my most recent key

publications were the Allergy College Practice Parameters for EIB and the American Thoracic Society (ATS)

EIB Guidelines. Additionally, I have a 30,000 word (125 pages) invited chapter for Comprehensive

Physiology in press.

Summation of qualifications:

• Two years as medical affairs consultant for Pharmaxis after leaving as Director of Medical Affairs.

• Acting KOL in respiratory for Merck Inc.

• Ten years Senior Physiologist at the Lake Placid USOTC where I developed the sports science

laboratory and was in charge of all physiology testing, blood work, asthma evaluations and lab

management. I performed environmental health related research on air pollution and muscle blood

flow in collaboration with the University of Pennsylvania.

• Ten years teaching graduate level Physiology and Laboratory Techniques, teaching in the Physician’s

Assistant (P.A.) program and supervising graduate students. My experience in research and

asthma/COPD clinical trials, muscle blood flow dynamics and air pollution toxicology augment my

background.

• I supervised Physiology Laboratory Coordinators, interns, volunteers, several graduate student

Master’s and Ph.D. theses and Medical Fellows from UPMC and Geisinger Health System.

• I presented lectures/symposiums on air pollution toxicology, cardiovascular and asthma research at

many National and International meetings.

• I presented Grand Rounds Lectures at major Universities such as Yale, Hartford Hospital, Geisinger,

UPMC, John’s Hopkins, University of West Virginia, Laval University, University of Rochester and

others.

• I was Principle Investigator on numerous research projects, with special contributions in asthma,

airborne particulate exposure and effects on blood flow dynamics.

• I have a substantial publishing record.

• I have served on the International Olympic Committee Medical Commission for both asthma and air

pollution.

• Member of three task force groups (ATS, AAAAI, Canadian EIB Technical Panel) for management

and treatment of exercise-induced asthma.

• Past Associate Editor of Medicine and Science in Sports and Exercise and Editorial Board member

and reviewer for several scientific/medical journals.

• Active FELLOW in the American College of Sports Medicine.

2

NAME Kenneth W. Rundell, Ph.D.

ADDRESS

WORK: Medical Affairs

Pharmaxis Inc.

Exton, PA 19341

610-***-**** ext 110

ace975@r.postjobfree.com

HOME: 605 Skyline Drive South

Clarks Summit, PA 18411

Phone 570-***-****

Cell 570-***-****

ace975@r.postjobfree.com

CITIZENSHIP

U.S.A.

EDUCATION

B.S. Kent State University (Biology)

M.S. Elmira College (Biology / Education)

Ph.D. (1991) Syracuse University (Physiology)

Dissertation, SUNY Health Science Center College

of Medicine, Department of Physiology.

POST GRADUATE EDUCATION

1991-92 Post Doctorate Research Fellow, Department of Physiology,

SUNY Health Science Center College of Medicine,

Syracuse, NY.

2003 Certified Radiographer, Pennsylvania State Board of Medicine and the Pennsylvania State

Board of Osteopathic Medicine.

2010-present Designated Pharmaceutical Representative, California State Board of

Pharmacy, Department of Consumer Affairs. License # 21064

3

RELEVANT PROFESSIONAL HISTORY

1989 Human Genetics instructor for the Program in Medicine. SUNY Health

Science Center College of Medicine at Syracuse.

1989-90 Graduate Teaching Assistant; Syracuse University.

1990-92 Laboratory Instructor; Cardiopulmonary Physiology. SUNY Health

Science Center College of Medicine at Syracuse.

1995-96 Adjunct Professor, North Country Community College, Saranac Lake, NY.

1992-2002 Senior Sport Physiologist. Sports Science & Technology Division, United

States Olympic Training Center; Lake Placid, NY.

2008-2010 Professor in the Basic Sciences. The Commonwealth Medical College;

Scranton, PA.

2007-2010 Merck Speaker Faculty, KOL

2009-2010 Pharmaxis Speaker Faculty/Consultant

2002-2010 Professor of Health Science, Director of Respiratory Research and the

Human Physiology Laboratory. Keith J. O’Neil Center For Healthy Families.

Marywood University. Scranton, PA 18509

8/2010-9/2012 Director of Medical Affairs, Pharmaxis Inc. One East Uwchlan Ave. Exton,

PA 119341.

9/2012-Present Consultant, Medical Affairs, Pharmaxis Inc. One East Uwchlan Ave. Exton,

PA 119341.

4

EDITORIAL RESPONSIBILITIES

Medicine and Science in Sports and Exercise, Reviewer, 1994-present.

The Journal of Strength and Conditioning Research, Reviewer, 1995-present.

The Journal of the American Medical Association, Reviewer, 1995-present.

Medicine and Science in Sports and Exercise, Editorial Board, 1997-present.

The Journal of Strength and Conditioning Research, Editorial Board, 1998-present.

The British Journal of Sports Medicine, Reviewer, 1999-present.

The Journal of Asthma. Reviewer. 2000-present.

World Anti-doping Agency. Grant Reviewer. 2000-present.

Chest, Reviewer, 2002-present.

Medicine and Science in Sports and Exercise, Associate Editor, 2002-2004.

Medicine and Science in Sports and Exercise, Associate Editor-In-Chief, 2004-2007.

Annals of Allergy, Asthma & Immunology, Reviewer, 2003-present.

American Journal of Respiratory Medicine, Reviewer, 2003-present.

European Journal of Applied Physiology, Reviewer, 2004-present.

European Respiratory Journal, Reviewer, 2004-present.

Physiol Meas., Reviewer, 2004-present.

Respiratory Medicine, Reviewer, 2005-present.

Scandinavian Journal of Medicine and Science in Sports, Reviewer, 2005-present.

Society for Free Radical Biology and Medicine (SFRM). Judge for submitted abstracts for 12th Annual

SFRM Meeting. Abstract Reviewer. 2005.

American Heart Association Mid Atlantic Consortium Study Section. 2006.

European Respiratory Society. Grant Reviewer. 2008.

SPECIAL TASK RESPONSIBILITIES

2007-present International Olympic Committee Air Quality Panel member. Charge: To

advise Olympic organizers on daily Beijing air quality concerning athlete health

risk from competition in sub-optimal air quality.

2008 International Olympic Committee Asthma Consensus Meeting member.

Charge: To define and publish guidelines and criteria for asthma medication use

during international competition.

2008 Technical Expert Panel (TEP) member of The Evidence-based Practice Centre

(EPC) for the Agency for Healthcare Research and Quality for Exercise-

Induced Bronchoconstriction and Asthma.

2008 Technical Expert Panel member of the American Thoracic Society Clinical

Practice Guideline entitled Management of Exercise-Induced

Bronchoconstriction. Charge: To develop and publish guidelines for physician

management of EIB.

2008 Exercise-Induced Bronchoconstriction Practice Parameter Task Force

member of the American Academy of Allergy Asthma and Immunology. Charge:

To develop and publish a practice parameter for physicians who provide care to

patients with EIB.

2009-present International Olympic Committee Asthma Panel member. Work with anti-doping

agencies as a liaison for the IOC in defining objective criteria (tests) and cut-off

values for asthma medicine use in Olympic competition.

20010-2012 Exercise-Induced Bronchoconstriction ATS Guidelines. Charge: To develop and

publish guidelines for physicians who provide care to patients

with EIB.

RECENT SYMPOSIA SPEAKER INVITATIONS

5

2010 American Academy of Allergy, Asthma & Immunology National Meeting, New

Orleans. Seminar discussion leader: Diagnosis and Management of Asthma and

Allergy in the Recreational Athlete.

2010 European Respiratory Society Annual Congress, Barcelona, Spain. Invited

Symposium speaker: Diagnosing Exercise Induced Asthma.

2010 CDC Physical Activity and Air Quality Workshop. Atlanta. Present and

participate in identifying research priorities and develop recommendations

for future guidance at federal, state and local levels.

2011 International Olympic Committee World Conference on Prevention of Injury &

Illness in Sport. Monaco. Symposium speaker: Respiratory health of elite athletes:

How to prevent airway dysfunction.

GRADUATE STUDENT THESIS COMMITTEES

Laval University University of Bloomsburg

Bernard Bilodeau, Ph.D., 1994 Claire E. Watson, M.S., 1998

University of Bloomsburg University of Bloomsburg

William Shearn, M.S., 1995 Garrett Felix, M.S., 1998

Boston University University of Massachusetts

Robert D. Douglas, M.S., 1996 Daine LaRoche, M.S., 1998

University of Bloomsburg University of Canberra

Joohee Im, M.S., 1998 Phillipa J. Daley, M.S., 1999

University of North Carolina Marywood University

Dan Judelson, M.S., 2001 Tina Evans, Ph.D., 2005

University of Connecticut Marywood University

Dan Judelson, Ph.D., 2005 Ryan Kohler, M.S., 2005

Alfred Hospital & Monash University University of Connecticut

Karen Holzer, Ph.D., 2005 Barry Spiering, Ph.D., 2006

Marywood University Marywood University

Emily Koziarski, M.S., 2006 Amanda Hollenbach. M.S., 2007

The University of British Columbia Temple University

Benjamin Sporer, Ph.D., 2006 Joohee Im Sanders, Ph.D., 2007

Marywood University Marywood University

Josh Slee, M.S., 2008 Kristin Evans, M.S., 2008

6

Marywood University Marywood University

Jessica Bodzio, M.S. 2009 Leanna Nastase, M.S. 2009

Marywood University Marywood University

Paul Cutrufello, Ph.D. 2009 Michelle Steigerwald, M.S. 2009

Marywood University University of Melbourne

Michelle Zinicola, M.S. 2009 Adam Castricum, M.S. 2009

GRANT SUPPORT

1996 United States Olympic Committee, Sport Science and Technology Grant

Committee: A test of the restricted blood flow hypothesis in speed skating,

$16,458; Co-PI.

1997 United States Olympic Committee, Sport Science and Technology Grant

Committee: Oxygen desaturation in the quadriceps during three separate alpine

ski events in U.S. junior alpine skiers, $12,695.

1998 United States Olympic Committee, Sport Science and Technology Grant Committee:

Responses during simulated competition, $1075, Co-PI.

1998-2005 NIH HL 44125 Grant: Physiology and Bioenergetics of Human Skeletal Muscle

Function No. 2. P.I.: Britton Chance, Consultant: K.W. Rundell. University of

Pennsylvania. $1,463,566; 5 year renewal.

2003-2004 Merck Medical School Research Award: Pathophysiology of Exercise-Induced

Asthma In Elite Athletes. P.I.: K.W. Rundell. Co-investigators: K.C. Beck, L.B.

Mayers. $50,000 plus 20% institutional overhead.

2003-2004 VIASYS Research Award: The Use of Impulse Oscillometry in Identifying Airway

Obstruction. P.I. K.W. Rundell. $5,000.

2004-2005 Immunocal Research Award: Cysteine donor supplementation and exercise-induced

airway hyperresponsiveness. P.I.: Kenneth W. Rundell, Ph.D. Co-Investigators:

Jennifer Baumann, RD, Tina M. Evans, Ph.D., ATC, Alan Levine, Ph.D. $65,000.

2004-2006 AHA Pennsylvania/Delaware Affiliate. Grant-In-Aid. Airborne ultrafine and fine

particulate matter: A cause of endothelial function in man? P.I. K.W. Rundell; Co-I:

P.A. Eden. Marywood University, $100,000.

2004-2006 NIH RFA-ES-03-010 R21 Grant: PM1 initiates TNF-a mediated endothelial

dysfunction. P.I.: K.W. Rundell; Co-I: P.A. Eden, Britton Chance. Marywood

University, University of Pennsylvania. $300,000. Pending.

2004-2008 NIH R01. Omega-3 fatty acids in airway hyperresponsiveness P.I.:T.D.

Mickleborough.; Co-I: K.W. Rundell University of Indiana, Marywood University. $1,300,000.

Pending.

2004-2008 NIH R01. Airway remodeling from fossil fuel generated PM exposure. P.I.: K.W.

Rundell; Co-I: M.S. Davis. Marywood University, Oklahoma State University. $1,500,000. 2004.

2004-2007 NIH R21. Airway oxidative stress and particulate matter exposure. P.I.: K.W.

Rundell. Marywood University. $350,000. Pending.

7

2004-2007 NIH R21. Oral cysteine donor in airway hyperresponsiveness. PI: Kenneth W.

Rundell, Ph.D. Co-Investigator: Timothy D. Mickleborough. Marywood University

$400,000.

2004 DURIP AFOSR BAA Equipment Grant. P.I.: Kenneth W. Rundell, Ph.D. $88,000.

2006 NIH R01. Particulate Matter Inhalation Causes Endothelial Dysfunction. P.I. K.W.

Rundell, Marywood University; CoI. Richard McAllister, University of

Missouri. $1,200,000. Pending.

2005 R01. Particulate Matter Inhalation and Vascular Function in Coal Miners. P.I. K.W.

Rundell, Marywood University; Co-I. William Beckett, University of Rochester.

$850,000.

2006 Pharmaxis Clinical Trial: The Role of Aridol in Asthma Diagnosis. Principal Investigator

K.W. Rundell, Marywood University. $212,926 Funded.

2006 R15. Particulate Matter Inhalation During Exercise Causes Airway Damage. Principal

Investigator: K.W. Rundell, Marywood University. $200,000. Pending.

2006 K.W. Rundell, Decreased S-Nitrosoglutathione Enhances Leukotriene Production after

Ultrafine Particle Inhalation. Principal Investigator: K. W. Rundell. Murray Award.

$5,000.

2006 Department of Defense PRMRP (peer reviewed medical research program).PI: Michael S.

Davis DVM PhD, Oklahoma State University, CoI: K. W. Rundell PhD, Marywood University, CoI:

W. Ensign PhD, Space & Naval Warfare Systems. “Mechanisms and preventative therapeutics for

exercise-induced immunosuppression and respiratory susceptibility to viral pathogens”.

2006 DURIP AFOSR BAA Equipment Grant. Principal Investigator: Kenneth W. Rundell, Ph.D.

$140,000.

2007 National Science Foundation. Major Instrument Program. Principal Investigator: Kenneth

W. Rundell, Ph.D. $120,000.

2007 SkyPharma Clinical Trial: A Randomized study comparing the safety and efficacy of

fluticasone and formoterol combination in a single inhaler. Principal Investigator: Kenneth W.

Rundell, Ph.D. Funding Amount: $92,696.

2007 Forest Research Institute, Almirall. Phase III Clinical Trial: A randomized. Double-blind,

placebo-controlled, parallel group, 6-week clinical study to assess the effect of inhaled aclidinium

bromide (LAS34373) 200 MG on exercise endurance and lung hyperinflation in patients with

moderate to severe chronic obstructive pulmonary disease (COPD). Principal Investigator: Kenneth

W. Rundell, Ph.D. Funding Amount: $63,022.

2007 World Anti Doping Agency. Decreased pulmonary artery pressure by oral sildenafil

ingestion at mild altitude and during exercise in air pollution increases exercise

performance. Principal Investigator: Kenneth W. Rundell, Ph.D. Funding: $90,000.

2008 Schering Plough. A 2-Week Double-Blind, Placebo-Controlled, Parallel Group Study

Comparing the Anti-inflammatory Effects of Low, Medium, and High Dose

Mometasone Furoate/Formoterol FumarateMDI Formulation and Medium Dose

Mometasone Furoate DPI and MDI Formulations in Adults with Persistent Allergic

Asthma (Schering Plough Research Institute). Principal Investigator: Kenneth W.

Rundell, Ph.D. Funding Amount: $74,020.

2008 Merck Inc. A Phase 1b Randomized, Placebo-Controlled Clinical Trial to Study the Safety

and Bronchodilatory Effect of MK-0476 in Patients with Chronic Asthma. Principal

Investigator: Kenneth W. Rundell, Ph.D. Funding: $124,399..

2008 Naturex Inc. The Effect of PowerGrape on Markers of Athletic Performance and Oxidative

Stress. Co-Investigator: Kenneth W. Rundell, Ph.D. Funding $155,000.

2009 Data Coordinating Center for the NHLBI Asthma Network (AsthmaNet) (U10). P.I. John

Weiler, MD, MBA, Compleware. Role Consultant.

8

2009 Merck Inc. Protocol 400-00. A Phase IIb, Randomized, Placebo-Controlled, Dose-Ranging

Study of Inhaled MK-0476 in Adult and Adolescent Patients with Chronic Asthma.

Principal Investigator: Kenneth W. Rundell, Ph.D.

2009 Merck Inc. Protocol 400-10. A Phase IIb, Randomized, Clinical Trial to Study the Safety

and Efficacy of Inhaled MK-0476 in Adult and Adolescent Patients with Chronic

Asthma (Open, Controlled, Extension to Protocol 400-00). Pending. Principal

Investigator: Kenneth W. Rundell, Ph.D. estimated start: end 1st quarter.

2009 Merck Inc. A Double-Blind, Placebo-Controlled, Multicenter, Crossover Study to Evaluate

the Effects of a Single Oral Dose of Montelukast, Compared With Placebo, on

Exercise-Induced Bronchoconstriction (EIB) in Pediatric

Patients Aged 4 to 14 Years. Principal Investigator: Kenneth W. Rundell. Funded.

2009 NIH R15 Progressive endothelial dysfunction and pulmonary hypertension in urban

children. Pending. Principal Investigator: Lilian Calderón-Garcidueñas

Role: Consultant

2009 NIH R15 Particulate matter inhalation augments leukotriene production via angiotensin II.

Principal Investigator: Kenneth W. Rundell, Ph.D. Pending. $410,993.

2010 Merck Inc. In vivo decrease in S-nitrosoglutathione and upregulation of 5-lipoxygenase by

high emissions particulate inhalation during exercise. Principal Investigator: Kenneth

W. Rundell. $90,748 To begin July 2010.

9

BOOK CHAPTERS

1. Burruss, P., J. Castellani, K.W. Rundell, A. Snyder. Roundtable: Winter Sports. In:

Gatorade Sports Science Exchange. 9 (4) Chapter 34, 1998.

2. Kearney, J.T., K.W.Rundell and R. Wilber. Measurement of work and power in sport. In:

Textbook of Sports Medicine Vol. I. Kirkendall & Garrett Eds. Williams & Wilkins.

Philadelphia, PA. 1999.

3. Foster, C., J.J. deKoning, K.W. Rundell, and A.C. Snyder. Applied sports physiology of

speed skating. In: Textbook of Sports Medicine Vol. I. Kirkendall & Garrett Eds.

Williams & Wilkins. Philadelphia, PA. 1999.

4. Von Duvillard, S., K.W. Rundell, B. Bilodeau and D. Bacharach. Biomechanics of

alpine and Nordic skiing. In: Textbook of Sports Medicine Vol. I. Kirkendall & Garrett Eds.

Williams & Wilkins. Philadelphia, PA. 1999.

5. Rundell, K.W. Chapter 6: Testing and screening for EIA. In: Exercise-induced asthma in

elite athletes. Rundell, K.W., R.L., Wilber, R., Lemanski, eds. Human Kinetics. 2002.

6. Rundell, K.W and D.A. Judelson. Chapter: Asthma and Exercise-Induced Asthma. In:

Clinical Exercise Physiology. LeMura, L. and Von Duvillard, S. eds. Lippincott Williams

& Wilkins. 2003.

7. Jenkinson, D. and K.W. Rundell. Chapter: Arthritis and Exercise. In: Clinical Exercise

Physiology. LeMura, L. and Von Duvillard, S. eds. Lippincott Williams & Wilkins. 2002.

8. Rundell, K.W. Chapter: The Cold Weather Athlete and Respiratory Pathophysiology. In:

The Winter Sports Medicine Handbook. Jim Moeller and Sami Rifat eds. 2003.

9. Rundell, K.W. and J. Im. The Utility of Near-Infrared Spectroscopy in Athlete

Assessment. In: Physiological Assessment of Human Performance. 2nd Edition. Carl

Foster and Peter Maud eds. Hunan Kinetics 2003.

10. Mickleborough, T.D. and K.W. Rundell. Omega-3 Fatty Acids and Airway

Hyperresponsiveness in Asthma. In: Focus on Dietary Fats Research. Nova Books 2004.

11. Rundell, K.W. The Impact of Air Pollution on Exercise. In: Regulatory Elements in

Exercise. In Press. 2008.

12. Rundell K.W. and P. Weiss. Pulmonary Concerns In: Exercise conditioning for persons

with chronic disability or disease. In Preparation. 2008.

BOOK

Rundell, K.W., R.L. Wilber, R. Lemanski, eds. EXERCISE-INDUCED ASTHMA IN ELITE

ATHLETES. Human Kinetics. Editor. 2002.

10

Over 100 Published Abstracts/National/Internatuional presentationsPUBLICATIONS (selected

peer reviewed papers from over 100)

Rundell, K.W., P.C. Tullson, and R.L. Terjung. Altered Kinetics of AMP Deaminase Induced By

Myosin Binding. American Journal of Physiology 263 (Cell Physiol. 32): C294-C299, 1991.

Rundell, K.W., P.C. Tullson, and R.L. Terjung. AMP Deaminase Binding In Contracting Rat

Skeletal Muscle. American Journal of Physiology 263 (Cell Physiol. 32): C287-C293, 1991.

Rundell, K.W., P.C. Tullson, and R.L. Terjung. In Vivo Binding of AMP Deaminase In Treadmill

Exercised Rats. Journal of Applied Physiology. 74 (4), 1993.

Bacharach, D.W., S. VonDuvallard, K.W. Rundell, J. Meng, M. Cring, L. Szmedra. and J. Castle.

Carbohydrate drink and cycling performance. J. Sports Med. and Phys. Fit. 34:2, 1994.

Boulay, M.R., K.W. Rundell, and D.L. King. Effect of slope variation and skating technique on

velocity in cross-country skiing. Med. Sci. Sports Exerc. 27 (2):281-287, 1995.

Rundell, K.W. and L.P. Pripstein. Physiological responses of speed skaters to treadmill low

walking and cycle ergometry. Int. J. Sports Med. 16 (5):304-308, 1995.

Rundell, K.W. and D.W. Bacharach. Physiological characteristics and performance of top U.S.

biathletes. Med. Sci. Sports Exerc. 27:281-287, 1995.

Rundell, K.W. Treadmill roller ski test predicts biathlon race results of top U.S. biathlon women.

Med. Sci. Sports Exerc. 27 (12): 1677-1685, 1995.

Rundell, K.W. Compromised oxygen uptake during treadmill inline skating in speed skaters.

Med. Sci. Sports Exerc. 28 (1): 120-127, 1996.

Bilodeau, B., K.W. Rundell, B. Roy, and M.R. Boulay. Kinematics of cross-country ski

racing. Med. Sci. Sports Exerc. 28 (1): 128-138, 1996.

Bacharach, D.W., M. Petit, and K.W. Rundell. Relationship of blood urea nitrogen to training

intensity of elite female biathlon skiers. J. Strength and Cond. Res. 10 (2): 105- 108, 1996.

Tullson, P.C., G. Arabadjis, K.W. Rundell, and R.L. Terjung. IMP reamination in rat skeletal

muscle fiber types. American Journal of Physiology (Cell Physiol 1996.

Tullson, P.C., K.W. Rundell, R.L. Sabina and R.L. Terjung. Creatine analog beta-

guandinopropionic acid alters skeletal muscle AMP deaminase activity. American Journal of

Physiology (Cell Physiol.). 270 (Cell Physiol. 39): C76-C85, 1996.

Rundell, K.W. Differences between treadmill running and treadmill roller skiing. J. Strength and

Cond. Res. 10 (3): 167-172, 1996.

Rundell, K.W. Effects of drafting during short track speed skating. Med. Sci. Sports Exerc. 29

(6): 765-771, 1996.

Osbeck, J.S., S.N. Maiorca, and K.W. Rundell. Validity of field testing to bobsled start

performance. J. Strength and Cond. Res. 10 (4): 1996.

11

Rundell, K.W., J. McCarthy. Effect of kinematic variables on performance in women during a

cross-country ski race. Med. Sci. Sports Exerc. 28 (11): 1413-1417, 1996.

Rundell, K.W., S. Nioka, B. Chance. Hemoglobin/myoglobin desaturation during speed skating.

Med. Sci. Sports Exerc. 29 (2) 248-258, 1997.

Rundell, K.W. and L. Szmedra. Energy cost of rifle carriage in biathlon skiing. Med. Sci. Sports

Exerc. 30 (4), 1998.

Gaskill, S.E., R.C. Serfass and K.W. Rundell. Upper body power comparisons between

groups of cross-country skiers and runners. Int. J. Sport Med. 20 (5) 290-294, 1999.

Foster, C., K.W. Rundell, A.C. Snyder, J. Stray-Gundersen, G. Kempers, N. Thometz, J. Broker, C.

Broshears, J. Hill, E. Knapp, M. Matiasek and J. Niak. Evidence for restricted muscle blood flow

during speed skating. Med. Sci. Sports Exerc. 31-10-143*-****, 1999.

Rundell, K.W., R.L. Wilber, L. Szmedra, D.M. Jenkinson, L.B. Mayers and J. Im. Exercise-

induced asthma screening of elite athletes: field vs. laboratory exercise challenge. Med. Sci. Sports

Exerc. 32(2) 309-316, 2000.

Wilber, R.L., K.W. Rundell, L. Szmedra, D.M. Jenkinson, J. Im and S.D. Drake. Incidence of

exercise-induced bronchospasm in Olympic Winter Sport Athletes. Med. Sci. Sports Exerc. 32(4)

732-737, 2000.

Staib, J.L., J. Im, Z. Caldwell and K.W. Rundell. Cross-country ski racing performance predicted

by aerobic and anaerobic double poling power. J. Strength and Cond. Res. 14(3) 282-288, 2000.

Szmedra L., K.W. Rundell and D.A. Ehrich. Hemodynamic and peripheral adaptations in patients

with coronary artery disease following six weeks of training. Clin. Exer. Physiol. 2(3) 121-128,

2000.

Mayers L.B., K.W. Rundell. Exercise-induced asthma. Olympic Coach. 10(3) 12-14, 2000.

Rundell, K.W., J. Im, L.B. Mayers, R.L. Wilber, L. Szmedra and H. Schmitz. Self-reported

symptoms and exercise-induced asthma in the elite athlete. Med. Sci. Sports Exerc. 33(2) 208-213,

2001.

Szmedra, L., J. IM, S. Nioka, B. Chance and K.W. Rundell. Hemoglobin/myoglobin oxygen

desaturation during alpine skiing. Med. Sci. Sports Exerc. 33(2) 232-236, 2001.

Im, J., S. Nioka, B. Chance and K.W. Rundell. Muscle oxygen desaturation is related to whole

body VO2 during cross-country ski-skating. Int. J. Sport Med. 22(5) 356-360, 2001.

Mayers, L.B., D.A. Judelson, B. Moriarty, and K.W. Rundell. Prevalence of body art (body

piercing and tattooing) in university undergraduates and incidence of medical complications. Mayo

Clin. Proc. 77, 29-34, 2002.

Rundell, K.W. and D.M. Jenkinson. Exercise-Induced Bronchoconstriction in Elite Athletes. J.

Sports Med. An invited review. 32(9) 383-600, 2002.

12

Mayers L.B., B.W. Moriarty, D.A. Judelson, K.W. Rundell. Tattooing and body piercing.

Pediatrics. 109(6) 1021-1027, 2003.

Rundell, K.W., B.A. Spiering, D.A. Judelson, and M.H. Wilson. Bronchoconstriction During

Cross-country Skiing: Is there really a refractory period? Med. Sci. Sports Exerc. 35(1) 18-26,

2003.

Spiering, B.A., M.H. Wilson, D.A. Judelson, and K. W. Rundell. Evaluation of Cardiovascular

Demands of Game Play and Practice in Women’s Ice Hockey. J. Strength and Cond. Res. 17(2)

329-33, 2003.

Rundell, K.W. and B.A. Spiering. Inspiratory Stridor in Elite Athletes. Chest. 123 468-474, 2003.

Rundell, K.W. High levels of airborne ultrafine and fine particulate matter in indoor ice arenas.

Inhal. Toxic. 15 237-250, 2003.

Hoffman, J.R., J. Im, K.W. Rundell, J. Kang, S. Nioka, B. A. Spiering, R. Kime, B. Chance. Effect

of Muscle Oxygenation during Resistance Exercise on Anabolic Hormone Response. Med. Sci

Sports Exerc. 35-11-192*-****, 2003.

Judelson, D.A., K.W. Rundell, K.C. Beck, T.M. King, and K.L. LaClair. Effect of high-intensity

submaximal work, with or without rest, on subsequent VO2max. Med. Sci Sports Exerc. 36(2) 292-

296, 2004.

Rundell, K.W. Pulmonary function decay among women ice hockey players: is there a

relationship to ice rink air quality? Inhal. Toxic. 16 (3) 117-123, 2004.

Rundell, K.W., B.A. Spiering, T.M. Evans, J.M. Baumann. Baseline lung function,

hyperresponsiveness, and asthma-like symptoms in elite women ice hockey players. Med. Sci

Sports Exerc. 36(3) 405-410, 2004.

Rundell, K.W., S.D. Anderson, B.A. Spiering. Eucapnic Voluntary hyperventilation for identifying

EIB in Elite Cold Weather Athletes. Chest. 125(3) 909-15, 2004.

Rundell, K.W. Overuse of Asthma Medication in Athletics? Med. Sci Sports Exerc. 36 (6) 925,

2004.

Spiering, B.A., D.A. Judelson, K.W. Rundell. Standardized ventilation rate for Eucapnic voluntary

ventilation: An evaluation. J Asthma. 41(7):745-9, 2004.

Rundell, K.W., B.A. Spiering J.M. Bauman, T.M. Evans. Montelukast has no ergogenic effects

during cycling in sub-freezing conditions. Med. Sci Sports Exerc. 36(11):1847-51, 2004.

Mickleborough, T.D., A.A. Ionescu, K.W. Rundell. Omega-3 Fatty Acids and Airway

Hyperresponsiveness in Asthma. J Alt Comp Med. 10(6):1067-75, 2004.

Rundell, K. W., B. A. Spiering, J.M. Bauman, T.M. Evans. Montelukast attenuates AHR in ice rink

athletes exposed to PM1 during exercise. Inhal. Toxic. 17(2):99-105, 2005.

13

Rundell, K. W., Spiering B.A J.M. Bauman, T.M. Evans. A single dose montelukast attenuates

airway hyperresponsiveness during cold air exercise and eucapnic voluntary hyperventilation. Brit J

Sports Med. 39:232-236, 2005.

Evans, T.M., K.W. Rundell, K.C. Beck, A.M. Levine, J.M. Baumann. Cold air inhalation does not

affect the severity of EIB following exercise or EVH. Med. Sci. Sports Exer. April; 37(4):544-9,

2005.

Kang, J., J.R. Hoffman, J. Im, B.A. Spiering, N.A. Ratamess, K.W. Rundell, S. Nioka, J. Cooper,

B. Chance. Evaluation of physiological responses during recovery following three resistance

exercise programs. J Strength Cond Research. May;19(2):305-9, 2005.

Mickleborough, T. D., K.W. Rundell. Dietary polyunsaturated fatty acids in asthma- and exercise-

induced bronchoconstriction. Eur J Clin Nutr. Jul 27, 2005.

Hoffman J.R., J. Im, B. Chance, K.W. Rundell, R. Kime, S. Nioka. The Effect of a Competitive

Collegiate Football Season on Power Performance and Muscle Oxygen Recovery Kinetics. J

Strength Cond Research. 19(3):509-513, 2005.

Rundell, K. W., T. M. Evans, M. F. Kertesz, J. M. Baumann Airway hyperresponsiveness measured

by impulse oscillometry following EVH.Ca J Respir. Jul-Aug;12(5):257-63, 2005.

Baumann, J.M., K.W. Rundell, T.M. Evans, A.M. Levine Effects of Cysteine Donor

Supplementation on Exercise-Induced Bronchoconstriction. Med Sci Sports Exer. 2005

Sep;37(9):1468-73.

Evans, T.M.

Contact this candidate